Cargando…
Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry
Autores principales: | Naik, Haley B., Alhusayen, Raed, Frew, John, Guilbault, Sandra, Hills, Nancy K., Ingram, John R., Kudlinski, Margaret V., Lowes, Michelle A., Marzano, Angelo Valerio, Paul, Maia, Villumsen, Bente, Yannuzzi, Christine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443529/ https://www.ncbi.nlm.nih.gov/pubmed/34537252 http://dx.doi.org/10.1016/j.jaad.2021.09.016 |
Ejemplares similares
-
Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic
por: Shah, Monica, et al.
Publicado: (2020) -
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022) -
Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021) -
Quality and engagement of online hidradenitis suppurativa information
por: Shukla, Neha R., et al.
Publicado: (2021) -
Special considerations for women with hidradenitis suppurativa
por: Collier, Erin, et al.
Publicado: (2020)